You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 6, June 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Use of Short-Course Class 1 Topical Glucocorticoid Under Occlusion for the Rapid Control of Erythrodermic Psoriasis

Jack L. Arbiser, MD, PhD; Karyn Grossman, MD; Elaine Kaye, MD; Kenneth A. Arndt, MD

Arch Dermatol. 1994;130(6):704-706.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

REPORT OF CASES

CASE 1

The patient was a 32-year-old man with a 15-year history of psoriasis, psoriatic arthritis, and multiple dermatologic hospitalizations. His psoriasis had been controlled by methotrexate intermittently over the past 10 years but was discontinued due to elevated liver function test results and the presence of positive serologic findings for hepatitis C. One week before admission, the patient discontinued his home UV-B therapy, and psoriatic erythroderma developed covering 70% to 80% of his total body surface area, with diffuse involvement of his scalp, trunk, and extremities. At the time of admission, the patient was an ill-appearing man complaining of chills, with a temperature of 37.5°C and a pulse rate of 100 beats per minute. Notable laboratory values were as follows: leukocytes, 13.9X109/L; hematocrit, 0.39; and platelets, 621X 109/L. Laboratory tests for electrolytes, serum urea nitrogen, and creatinine showed findings within normal limits. . . . [Full Text PDF of this Article]


Author Affiliations

Harvard Medical School, Boston, Mass; Harvard Medical School, Boston; Massachusetts General Hospital, Boston; Beth Israel Hospital, Boston



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.